Other antineoplastic Drugs

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
PLX4032 PLX4032 918504-65-1 C23H18ClF2N3O3S
Pemetrexed Disodium Pemetrexed Disodium 150399-23-8 C20H22N5NaO6
Bortezomib Bortezomib 179324-69-7 C19H25BN4O4
Carboplatin Carboplatin 41575-94-4 C6H12N2O4Pt
Cisplatin Cisplatin 15663-27-1 Cl2H6N2Pt
Cediranib Cediranib 288383-20-0 C25H27FN4O3
Combretastatin A4 phosphate disodium salt Combretastatin A4 phosphate disodium salt 168555-66-6 C18H19O8P.2Na
Lenalidomide Lenalidomide 191732-72-6 C13H13N3O3
Oxaliplatin Oxaliplatin 61825-94-3 C8H12N2O4Pt
Mitotan Mitotan 53-19-0 C14H10Cl4
1822357-78-7 1822357-78-7 1822357-78-7
Linrodostat mesylate Linrodostat mesylate 2221034-29-1 C25H28ClFN2O4S
Pelidotin Pelidotin 1438849-92-3 C68H100N12O14S
Muparfostat sodium Muparfostat sodium 1020105-88-7 C12H14O35PS7.(C6H7O14S3.3Na)n.9Na
Tanomastat Tanomastat 179545-77-8 C23H19ClO3S
Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]car... Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]car... 1182215-65-1
RAD51-IN-2 RAD51-IN-2 2301085-04-9 C27H40N4O6S2
Yttrium (90Y) Clivatuzumab Tetraxetan Yttrium (90Y) Clivatuzumab Tetraxetan 943976-23-6
Farletuzumab Farletuzumab 896723-44-7
Drozitumab Drozitumab 912628-39-8
Brontictuzumab Brontictuzumab 1447814-75-6
Vandortuzumab Vedotin Vandortuzumab Vedotin 1471985-92-8
Zanidatamab Zanidatamab 2169946-15-8
Cofetuzumab Cofetuzumab 1869928-62-0
Amivantamab Amivantamab 2171511-58-1
Axatilimab Axatilimab 2155851-88-8
Pyrazolo[4,3-b]pyrido[4,3-e][1,4]diazepine, 5-(2-chlorophenyl)-1,2-dihydro-3-methyl-8-(4-morpholinyl)- Pyrazolo[4,3-b]pyrido[4,3-e][1,4]diazepine, 5-(2-chlorophenyl)-1,2-dihydro-3-methyl-8-(4-morpholinyl)- 2230490-29-4 C20H19ClN6O
Carzelesin Carzelesin 119813-10-4 C41H37ClN6O5
Livmoniplimab Livmoniplimab 2412004-88-5
Silverfluoroborate Silverfluoroborate 1404-20-2
D-Aminolevulinicacidmethylesterhydrochloride D-Aminolevulinicacidmethylesterhydrochloride 33320-16-0 C6H12ClNO3
α-Interferon α-Interferon 308067-63-2
Simtrazene Simtrazene 5579-27-1 C14H16N4
Linavonkibart Linavonkibart 2640981-30-0
Research Grade Ipafricept  (DHK29201) Research Grade Ipafricept (DHK29201) 1391727-24-4
Bocodepsin Bocodepsin 1834513-65-3 C26H39N5O6S2
Cobomarsensodium Cobomarsensodium 1848257-85-1
Oberotatug Oberotatug 2641919-34-6
Verzistobart Verzistobart 2649466-18-0
/ / 2641651-83-2 C24H27Cl2F3N6O.C6H6O3S
Rosomidnar Rosomidnar 871597-03-4
ADOZELESIN ADOZELESIN 110314-48-2 C30H22N4O4
Research Grade Onvapegleukin Alfa Research Grade Onvapegleukin Alfa 2764760-02-1
5-[(2-Aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol 5-[(2-Aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol 119221-49-7
N-(Phosphonoacetyl)-L-aspartic acid 1,4-disodium salt N-(Phosphonoacetyl)-L-aspartic acid 1,4-disodium salt 66569-27-5 C6H8NNa2O8P
Teroxirone Teroxirone 59653-73-5 C12H15N3O6
Dibenz[cd,g]indazol-6(2H)-one,5-[(3-aminopropyl)amino]-7,10-dihydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-,hydrochloride (1:2) Dibenz[cd,g]indazol-6(2H)-one,5-[(3-aminopropyl)amino]-7,10-dihydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-,hydrochloride (1:2) 105118-12-5 C21H25N5O4.2ClH
MGA271 MGA271 1353485-38-7
Tucidinostat (Chidamide) Tucidinostat (Chidamide) 1616493-44-7 C22H19FN4O2
Milademetan Milademetan 1398568-47-2 C30H34Cl2FN5O4
PSMA-617 PSMA-617 1702967-37-0 C49H71N9O16
Molibresib besylate Molibresib besylate 1895049-20-3 C28H28ClN5O5S
Sulfamic acid, [(1R,2S,4R)-4-[[5-[[4-[(1R)-7-chloro-1,2,3,4-tetrahydro-1-isoquinolinyl]-5-methyl-2-thienyl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester Sulfamic acid, [(1R,2S,4R)-4-[[5-[[4-[(1R)-7-chloro-1,2,3,4-tetrahydro-1-isoquinolinyl]-5-methyl-2-thienyl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester 1858276-04-6 C25H28ClN5O5S2
Lorvotuzumab Mertansine Lorvotuzumab Mertansine 1008106-64-6
Verubulin Verubulin 827031-83-4 C17H17N3O
ON 013105 ON 013105 865784-01-6 C19H21Na2O10PS
8-Chloro-cAMP 8-Chloro-cAMP 41941-56-4 C10H11ClN5O6P
LyMphoCide LyMphoCide 501423-23-0
INNO206 INNO206 1361644-26-9 C37H42N4O13
Icrucumab Icrucumab 1024603-92-6
Flanvotumab Flanvotumab 1188277-05-5
Vorsetuzumab Mafodotin Vorsetuzumab Mafodotin 1165741-01-4
Lenzilumab Lenzilumab 1229575-09-0
Tafasitamab Tafasitamab 1422527-84-1
Inebilizumab Inebilizumab 1299440-37-1
Vadastuximab Vadastuximab 1436390-63-4
Depatuxizumab Mafodotin Depatuxizumab Mafodotin 1585973-65-4
Belantamab Belantamab 2061894-48-0
Cetuximab Sarotalocan Cetuximab Sarotalocan 2166339-33-7
Epcoritamab Epcoritamab 2134641-34-0
Tavolimab Tavolimab 1635395-25-3
Bisantrene dihydrochloride Bisantrene dihydrochloride 71439-68-4 C22H22N8.2(HCl)
2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro- 2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro- 2230263-60-0 C28H36N6O3
Pavurutamab Pavurutamab 2250292-39-6
Runimotamab Runimotamab 2361325-98-4
Mupadolimab Mupadolimab 2451856-97-4
Tulmimetostat Tulmimetostat 2567686-02-4 C28H36ClN3O5S
Etoprine Etoprine 18588-57-3 C12H12Cl2N4
3-(4-(4-aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl)-2-hydroxybenzonitrile hydrochloride 3-(4-(4-aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl)-2-hydroxybenzonitrile hydrochloride 2361216-83-1 C27H23ClF2N4O
Osemitamab Osemitamab 2460539-61-9
Forimtamig Forimtamig 2649379-96-2
Research Grade Vandortuzumab  (DHJ76001) Research Grade Vandortuzumab (DHJ76001) 1557989-52-2
Research Grade Visugromab  (DHJ48302) Research Grade Visugromab (DHJ48302) 2556646-63-8
Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]- Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]- 2821770-49-2 C55H71N9O13S
BMS 181176 BMS 181176 119673-08-4 C33H34Cl2N4O7
Olaptesedpegol Olaptesedpegol 1390628-22-4
Patritumab deruxtecan Patritumab deruxtecan 2227102-46-5
Datopotamab deruxtecan Datopotamab deruxtecan 2238831-60-0
mitogillin mitogillin 1403-99-2
Mitosper Mitosper 11056-15-8
aderbasib aderbasib 791828-58-5 C21H28N4O5
Sivifene Sivifene 2675-35-6 C19H14N4O6
Leurosine Sulfate Leurosine Sulfate 54081-68-4 C46H58N4O13S
MITOCROMIN MITOCROMIN 11043-98-4
Unii-W6E275iurx Unii-W6E275iurx 132937-89-4 C44H60Cl4N10O9
IPI-926 IPI-926 1037210-93-7 C29H48N2O3S
Denibulin Hydrochloride Denibulin Hydrochloride 779356-64-8 C18H20ClN5O3S
Cevipabulin FuMarate Cevipabulin FuMarate 849550-69-2 C22H22ClF5N6O5
SN 2310 SN 2310 850728-18-6 C55H72N2O9
PCI-24781 HCL PCI-24781 HCL 783356-67-2 C21H24ClN3O5
HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase
Copyright © 2016 ChemicalBook All rights reserved.